Top compounds associated with response to OR2L3


Feature Type Standardized
Nominal ANOVA
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.066 0.05
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.064 0.05
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.061 0.06
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.059 0.06
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.06
mRNA Doxorubicin gCSI pan-cancer AAC -0.091 0.07
mRNA Imatinib CTRPv2 pan-cancer AAC 0.065 0.07
Download CSV